Literature DB >> 320052

Gluconeogenesis: methodological approaches in vivo.

J L Chiasson, J E Liljenquist, W W Lacy, A S Jennings, A D Cherrington.   

Abstract

The complexity of the process of gluconeogenesis makes it very difficult to study in vivo. Of the many approaches used to study this process, none have proven ideal. The arterial-hepatic venous catheterization technique can provide accurate determination of the net splanchnic uptake of the various gluconeogenic precursors but gives no information as to their fate once extracted. The infusion of a labeled precursor, such as [14C]alanine, will provide qualitative information about the fate of the labeled substrate but, without complicated kinetic analysis, will not provide quantitative information on the conversion of the precursor to glucose. Though each of these individual techniques has major limitations in the study of gluconeogenesis, various combinations of these methods can provide further insight into the regulation of this complicated process. By combining the arterial-hepatic venous catheterization technique with the infusion of a labeled precursor, the splanchnic extraction of the precursor can be measured as well as the amount of the extracted precursor that is converted to glucose. The concomitant infusion of two isotopes (a 14C-labeled gluconeogenic precursor to assess substrate conversion to glucose and 3H-labeled glucose to measure glucose turnover) can also provide an accurate determination of the amount of circulating precursor that is converted to glucose. The latter technique provides no information on the splanchnic extraction of the precursor but has the advantage of being less invasive and, therefore, more applicable to man. The last two techniques measure accurately the direct conversion of the circulating precursor to glucose and, therefore, provide reliable index of gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320052

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  27 in total

1.  The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats.

Authors:  Ping-Ping Li; Song Shan; Yue-Teng Chen; Zhi-Qiang Ning; Su-Juan Sun; Quan Liu; Xian-Ping Lu; Ming-Zhi Xie; Zhu-Fang Shen
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

2.  In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.

Authors:  G R Freidenberg; S L Suter; R R Henry; D Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.

Authors:  A W Thorburn; B Gumbiner; F Bulacan; P Wallace; R R Henry
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

4.  Comparison of the direct and indirect effects of epinephrine on hepatic glucose production.

Authors:  C A Chu; D K Sindelar; D W Neal; E J Allen; E P Donahue; A D Cherrington
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

Authors:  C Fanelli; S Calderone; L Epifano; A De Vincenzo; F Modarelli; S Pampanelli; G Perriello; P De Feo; P Brunetti; J E Gerich
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal.

Authors:  S Rubenfeld; A J Garber
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

7.  Effect of glucagon on glucose production during insulin deficiency in the dog.

Authors:  A D Cherrington; W W Lacy; J L Chiasson
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

8.  Lipid transport in the human newborn. Palmitate and glycerol turnover and the contribution of glycerol to neonatal hepatic glucose output.

Authors:  P F Bougnères; I E Karl; L S Hillman; D M Bier
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

9.  Effect of L-alanine infusion on gluconeogenesis and ketogenesis in the rat in vivo.

Authors:  P T Ozand; W D Reed; R L Hawkins; J H Stevenson; J T Tildon; M Cornblath
Journal:  Biochem J       Date:  1978-03-15       Impact factor: 3.857

10.  Effect of major hepatectomy on glucose and lactate metabolism.

Authors:  R Chioléro; L Tappy; M Gillet; J P Revelly; H Roth; C Cayeux; P Schneiter; X Leverve
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.